The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconciling business, medical and ethical needs' in a series of four lectures looking at t ... Show More
Jun 2009
Pharmaceutical Companies, Government and Society
This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment.
37m 8s
Apr 2024
The Power of Drug Discovery with Philip Tagari
<p>Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.</p><p>Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery p ... Show More
31m 36s
Jun 2024
Unlocking Growth: How Digital Innovation is Transforming Commercial Manufacturing
In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares h ... Show More
33m 42s